A study of the Indian chemical industry conducted by Tata Strategic Management, the Federation of Indian Chambers of Commerce & Industry and Roland Berger estimated the Indian chemical industry to be $83 billion in fiscal 2010. Base chemicals accounted for 53% of the industry. Growing at a projected rate of 5%, the Indian organic chemicals […]
The UK’s R&D budget has been reduced to £6.4 billion ($10 billion) per year for the next four years, as part of a package of public spending cuts. In real terms, the freeze will amount to about a 10% reduction. Around £2 million ($3.1 million) of the UK’s annual science budget is given directly to […]
The China-based Pharmaceutical Association has approved a new plan to put more emphasis on quality control. The plan, set to be announced next year by the State Food and Drug Administration, should eliminate some unqualified producers in the industry. The nonprofit association represents 37 multinational pharmaceutical manufacturers, mostly from Europe, the US and Japan. The […]
Spanish scientists have voiced their concern about the scale of spending cuts outlined in the country’s draft 2011 science budget, which was presented to Spain’s Congress on September 30. In 2011, the Science and Innovation Ministry’s draft budget will decrease 1.65%, according to Science Minister Cristina Garmendia, who added the budget would be similar to […]
Companies and charities will not likely compensate for the government’s looming science budget cuts. They say that it is not their responsibility to make up for the difference in university research if the proposed cuts are approved. UK R&D spending from the private sector totals about £13 billion ($20.6 billion) a year. Much of that […]
Cuts in France’s 2011 budget were recently announced, and the only two ministries to dodge the cuts were the ministry of science and education and the justice ministry. In the wake of the budget announcement, Minister for Research and Higher Education Valérie Pécresse announced that her ministry’s budget will be €4.7 billion ($6.5 billion) more […]
Singapore plans to reduce guaranteed funds for biomedical scientists in order to increase the return on investments. Currently, the Agency for Science, Technology and Research guarantees 100% funding. Under the new policy, which takes effect April 1 and will be in place for at least a year, Singapore’s biomedical research institutes will vie for 30% […]
Australian business expenditure on R&D (BERD) for the financial year ended June 30, 2009, was AUD $16.9 billion ($16.3 billion), an increase of 13% in current price terms and 9% in constant prices. BERD as a proportion of GDP increased from 1.26% to 1.34%. Capital expenditures other than land, buildings and other structures totaled AUD […]
Following news that the country is spending less on R&D than previously thought, Chile’s new government plans to improve R&D spending. Chile’s R&D investment, which was almost 0.7% of the GDP in 2004, was only 0.4% in 2008. A recent survey estimated the 2009 percentage may have been even lower because of the global financial […]
Chinese researchers’ initiatives could put them ahead in international efforts to build a complete catalog of human proteins. In January, the Human Proteome Organization (HUPO) made strides toward the effort by coordinating the Human Proteome Project (HPP), whose goal is to identify the approximate 21,000 proteins encoded by the human genome, offer a detailed description […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

